Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 1;47(2):e439-e446.
doi: 10.1097/MAO.0000000000004729. Epub 2025 Nov 11.

Proteomic Analysis Identifies Novel Plasma Biomarkers in Patients With Vestibular Schwannoma

Han T N Nguyen  1 , Hsuan-Chih Kuo  1 , Sasa Vasilijic  2 , Giorgia Giordano  3 , Towia Libermann  4 , Konstantina M Stankovic  2 , Yin Ren  1
Affiliations

Proteomic Analysis Identifies Novel Plasma Biomarkers in Patients With Vestibular Schwannoma

Han T N Nguyen et al. Otol Neurotol. .

Abstract

Hypothesis: Patients with sporadic vestibular schwannoma (VS) have unique plasma protein biomarkers that distinguish them from patients without VS.

Background: No reliable molecular biomarker of VS exists. MRI biomarkers offer limited insight into VS pathophysiology. Identification of plasma biomarkers could enhance disease prognostication and guide treatment decisions.

Methods: A high-throughput DNA aptamer-based proteomic analysis was performed in plasma samples from 12 individuals, 6 with sporadic, non-irradiated and growing VS and 6 age-matched and sex-matched healthy controls (HCs). Dysregulated proteins were identified using a cutoff value of |log 2 foldchange|>1 and padj <0.05. Enriched pathways were determined using Ingenuity Pathway and STRING bioinformatic analysis. Biomarker expression was validated in an established human schwannoma cell line and primary VS culture.

Results: A total of 7310 proteins were profiled. Of 1499 differentially expressed proteins, 152 (10%) were upregulated and 264 (18%) were downregulated in VS. There was an enrichment in cancer proliferation, protein catabolism, and immune cell activation processes. A panel of 40 proteins distinguished VS from HC, accounting for 84% of the variance on principal component analysis. These included members of NF-κB and Wnt signaling pathways (NFKBIA, WNT10A, and WNT16). IGFBP-2 and FCGR3A mRNA expression were significantly elevated in schwannoma cells. Hepcidin (HAMP), a regulator of iron homeostasis that influences tumor growth, was highly expressed in human VS tissue and enriched in primary VS culture secretion.

Conclusions: Proteomic analysis of VS patient plasma identified several disease-classifying biomarkers. Hepcidin warrants further investigation into its role in VS progression.

Keywords: Acoustic neuroma; Hepcidin; Proteomics; Vestibular schwannoma.

PubMed Disclaimer

Conflict of interest statement

The authors disclose no conflicts of interest.

References

    1. Carlson ML, Link MJ. Vestibular schwannomas. N Engl J Med 2021;384:1335–48.
    1. Marinelli JP, Lees KA, Lohse CM, et al. Natural history of growing sporadic vestibular schwannomas: an argument for continued observation despite documented growth in select cases. Otol Neurotol 2020;41:e1149–e1153.
    1. Macielak RJ, Harris MS, Mattingly JK, Shah VS, Prevedello LM, Adunka OF. Can an Imaging marker of consistency predict intraoperative experience and clinical outcomes for vestibular schwannomas? A retrospective review. J Neurol Surg B Skull Base 2021;82:251–257.
    1. Brown A, Early S, Vasilijic S, Stankovic KM Sporadic Vestibular Schwannoma Size and Location Do not Correlate With the Severity of Hearing Loss at Initial Presentation. Front Oncol. Published online 2022 doi:10.3389/fonc.2022.836504
    1. Nguyen HTN, Duhon BH, Kuo HC, et al. Matrix metalloproteinase 9: An emerging biomarker for classification of adherent vestibular schwannoma. Neurooncol Adv 2024;6. doi:10.1093/noajnl/vdae058 - DOI